{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:09:22Z","timestamp":1781114962049,"version":"3.54.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["U01-HL146193"],"award-info":[{"award-number":["U01-HL146193"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) affects over 37 million adults in the United States, and people living with HIV (PLWH) are at greater risk for progression to end-stage kidney disease. Although both conditions are common among PLWH, the potential pathways through which depression and use of medications with nephrotoxic potential may influence CKD development remain underexplored. We evaluated the relationships of depression and nephrotoxic medication use with CKD prevalence among PLWH, and investigated the potential mediating effects of these factors on the pathway to CKD among PLWH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed data from the Multicenter AIDS Cohort Study (MACS)\/Women\u2019s Interagency HIV Study (WIHS) Combined Cohort Study (MWCCS). Baseline CKD prevalence was estimated using Visit 101 only (November 2020-September 2021). To examine associations with CKD over time, we fit generalized estimating equations (GEE) using repeated observations from Visits 101\u2013103 (November 2020-March 30, 2023) with a Poisson distribution and log link to estimate relative risks (RR) and account for within-participant correlation. Counterfactual-based causal mediation analyses were conducted using Visit 101\u2013103 data to evaluate whether elevated depressive symptoms (CES-D\u2009\u2265\u200916) or nephrotoxic medication use mediated the HIV-CKD association while adjusting for baseline confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 2,530 participants [1,622 PLWH and 908 people living without HIV (PLWoH)], CKD prevalence was higher in PLWH (18.1%) compared to PLWoH (9.7%). In univariate repeated-measures GEE models, HIV serostatus (RR\u2009=\u20091.37, 95% CI: 1.28\u20131.48, p\u2009&lt;\u20090.0001) and Nephrotoxic medication use (RR\u2009=\u20091.49, 95% CI: 1.30\u20131.71, p\u2009&lt;\u20090.0001) were significantly associated with higher CKD risk. Several covariates were also associated with CKD in univariate GEE models, including age (RR\u2009=\u20091.03, 95% CI: 1.03\u20131.03, p\u2009&lt;\u20090.0001), non-Hispanic Black (RR\u2009=\u20091.19, 95% CI: 1.11\u20131.27, p\u2009&lt;\u20090.0001) compared to non-Hispanic White, diabetes (RR\u2009=\u20091.26, 95% CI: 1.17\u20131.35, p\u2009&lt;\u20090.0001), and higher income (RR\u2009=\u20090.99, 95% CI: 0.98\u20131.00, p\u2009=\u20090.005). Depressive symptoms were not associated with CKD in mediation-model adjusted analyses and did not mediate the HIV-CKD association. Mediation analysis indicated that nephrotoxic medication use accounted for a small but significant proportion of the HIV-CKD association (indirect effect OR = 1.02, 95% CI: 1.00\u20131.03, p\u2009=\u20090.02).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While it is well established that PLWH have a higher prevalence of CKD compared to PLWoH, our findings suggest that nephrotoxic medication use may modestly amplify this risk. Although most of the risk appears to be attributable to the direct effects of HIV, these medications represent a modifiable contributor. PLWH receiving such treatments may benefit from closer kidney function monitoring. Future research should evaluate psychosocial contributors to CKD using designs that incorporate clinical depression diagnosis and treatment data to clarify depression-related pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0336467","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:47:31Z","timestamp":1781113651000},"page":"e0336467","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["HIV, nephrotoxic medications, and chronic kidney disease: Prevalence, risk factors, and mediation analyses among people with and without HIV enrolled in the Multicenter AIDS Cohort Study (MACS)\/ Women\u2019s Interagency HIV Study (WIHS) combined cohort study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-0975","authenticated-orcid":true,"given":"Yue","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique L.","family":"Musselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain","family":"Mithani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Margolick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Palella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Mimiaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Bodnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Konkle-Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Wingood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Westreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Seaberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Lauren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardge","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8902-9576","authenticated-orcid":true,"given":"Michelle M.","family":"Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Blair","family":"Spence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Feaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Alcaide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"pone.0336467.ref001","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/IJNRD.S93887","article-title":"Update on current management of chronic kidney disease in patients with HIV infection","volume":"9","author":"NE Diana","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"1","key":"pone.0336467.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000526868","article-title":"HIV-Associated Nephropathy in 2022","volume":"3","author":"FB Rivera","year":"2023","journal-title":"Glomerular Dis"},{"issue":"5","key":"pone.0336467.ref003","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1053\/j.ajkd.2011.10.050","article-title":"Risk factors for ESRD in HIV-infected individuals: Traditional and HIV-related factors","volume":"59","author":"V Jotwani","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"pone.0336467.ref004","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1468-1293.2012.01045.x","article-title":"End-stage renal disease and dialysis in HIV-positive patients: Observations from a long-term cohort study with a follow-up of 22 years","volume":"14","author":"M Bickel","year":"2013","journal-title":"HIV Med"},{"issue":"6","key":"pone.0336467.ref005","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.semnephrol.2008.08.005","article-title":"HIV-associated nephropathy: Clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy","volume":"28","author":"CM Wyatt","year":"2008","journal-title":"Semin Nephrol"},{"issue":"4","key":"pone.0336467.ref006","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/IM9.0000000000000132","article-title":"Prevalence of depression in elderly people living with HIV: A systematic review and meta-analysis","volume":"5","author":"GY Ahmed","year":"2023","journal-title":"Infect Microb Dis"},{"issue":"6","key":"pone.0336467.ref007","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.18441120","article-title":"Association of depressive symptoms with rapid kidney function decline in adults with normal kidney function","volume":"16","author":"Z Zhang","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"pone.0336467.ref008","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12882-022-02957-7","article-title":"The synergistic effect of depression and moderate chronic kidney disease on the all-cause and cardiovascular disease mortality among adults: A retrospective cohort study","volume":"23","author":"F Meng","year":"2022","journal-title":"BMC Nephrol"},{"issue":"4","key":"pone.0336467.ref009","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s11606-019-05557-8","article-title":"Use of Potentially Nephrotoxic Medications by U.S. Adults with Chronic Kidney Disease: NHANES, 2011-2016","volume":"35","author":"S Kurani","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"3","key":"pone.0336467.ref010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/diseases10030048","article-title":"The effects of use of long-term second-generation antipsychotics on liver and kidney function: A prospective study","volume":"10","author":"E Papatriantafyllou","year":"2022","journal-title":"Diseases"},{"issue":"10","key":"pone.0336467.ref011","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s40263-022-00952-y","article-title":"Psychotropic drugs and adverse kidney effects: A systematic review of the past decade of research","volume":"36","author":"JJ Damba","year":"2022","journal-title":"CNS Drugs"},{"issue":"5","key":"pone.0336467.ref012","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"L Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"pone.0336467.ref013","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/aje\/kwab050","article-title":"Characteristics of the MACS\/WIHS Combined Cohort Study: Opportunities for research on aging with HIV in the Longest US Observational Study of HIV","volume":"190","author":"G D\u2019Souza","year":"2021","journal-title":"Am J Epidemiol"},{"issue":"1","key":"pone.0336467.ref014","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"A Levin","year":"2013","journal-title":"Kidney International Supplements"},{"issue":"3","key":"pone.0336467.ref015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D Scale: A self-report depression scale for research in the general population","volume":"1","author":"LS Radloff","year":"1977","journal-title":"Applied Psychological Measurement"},{"issue":"4","key":"pone.0336467.ref016","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00042560-200208010-00005","article-title":"Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women","volume":"30","author":"JA Cook","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"pone.0336467.ref017","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/13607863.2017.1423037","article-title":"Optimal metrics for identifying long term patterns of depression in older HIV-infected and HIV-uninfected men who have sex with men","volume":"23","author":"NM Armstrong","year":"2019","journal-title":"Aging Ment Health"},{"key":"pone.0336467.ref018","author":"JD Preston","year":"2023"},{"issue":"7","key":"pone.0336467.ref019","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40264-023-01312-5","article-title":"Expert consensus on the nephrotoxic potential of 195 medications in the non-intensive care setting: A modified delphi method","volume":"46","author":"BA Stottlemyer","year":"2023","journal-title":"Drug Saf"},{"issue":"4","key":"pone.0336467.ref020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/aje\/kws412","article-title":"The table 2 fallacy: Presenting and interpreting confounder and modifier coefficients","volume":"177","author":"D Westreich","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"1","key":"pone.0336467.ref021","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ki.2013.77","article-title":"Prevalence of depression in chronic kidney disease: Systematic review and meta-analysis of observational studies","volume":"84","author":"S Palmer","year":"2013","journal-title":"Kidney Int"},{"issue":"7","key":"pone.0336467.ref022","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf186","article-title":"Chronic kidney disease is associated with incident depression requiring treatment: A retrospective cohort study","volume":"18","author":"A Kommer","year":"2025","journal-title":"Clin Kidney J"},{"key":"pone.0336467.ref023","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5414\/CNP83S032","article-title":"HIV and chronic kidney disease","volume":"83","author":"S Naicker","year":"2015","journal-title":"Clin Nephrol"},{"issue":"1","key":"pone.0336467.ref024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jinf.2013.03.008","article-title":"High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians","volume":"67","author":"FS Sarfo","year":"2013","journal-title":"J Infect"},{"issue":"14","key":"pone.0336467.ref025","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1097\/QAD.0000000000002331","article-title":"Serious clinical events in HIV-positive persons with chronic kidney disease","volume":"33","author":"L Ryom","year":"2019","journal-title":"AIDS"},{"issue":"1","key":"pone.0336467.ref026","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13148-021-01082-w","article-title":"DNAm-based signatures of accelerated aging and mortality in blood are associated with low renal function","volume":"13","author":"PR Mat\u00edas-Garc\u00eda","year":"2021","journal-title":"Clin Epigenetics"},{"issue":"6","key":"pone.0336467.ref027","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.ajkd.2019.08.026","article-title":"Perceived health and quality of life in patients with CKD, including those with kidney failure: Findings from national surveys in France","volume":"75","author":"K Legrand","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"24","key":"pone.0336467.ref028","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMra1508467","article-title":"Kidney diseases associated with human immunodeficiency virus infection","volume":"377","author":"SD Cohen","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0336467.ref029","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/ckj\/sfv015","article-title":"Atazanavir nephrotoxicity","volume":"8","author":"M Hara","year":"2015","journal-title":"Clin Kidney J"},{"issue":"1","key":"pone.0336467.ref030","first-page":"817","article-title":"An overview of tenofovir and renal disease for the HIV-treating clinician","volume":"19","author":"WDF Venter","year":"2018","journal-title":"South Afr J HIV Med"},{"issue":"9","key":"pone.0336467.ref031","article-title":"Tenofovir-induced renal dysfunction among HIV-infected patients: A systematic review","volume":"15","author":"YM Shivakumar","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"pone.0336467.ref032","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.ackd.2009.08.006","article-title":"HIV and CKD epidemiology","volume":"17","author":"JA Winston","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"pone.0336467.ref033","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11920-014-0530-4","article-title":"Depression in HIV infected patients: a review","volume":"17","author":"MG Nanni","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"pone.0336467.ref034","year":"2023"},{"issue":"1","key":"pone.0336467.ref035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/j.ajkd.2012.02.325","article-title":"Association of symptoms of depression with progression of CKD","volume":"60","author":"YC Tsai","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"pone.0336467.ref036","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00006842-199701000-00004","article-title":"Screening for depression in diabetes using the Beck Depression Inventory","volume":"59","author":"PJ Lustman","year":"1997","journal-title":"Psychosom Med"},{"issue":"5","key":"pone.0336467.ref037","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1176\/appi.psy.47.5.376","article-title":"The diagnosis of major depression in patients with cancer: A comparative approach","volume":"47","author":"Y Guo","year":"2006","journal-title":"Psychosomatics"},{"issue":"9","key":"pone.0336467.ref038","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s40620-024-01998-5","article-title":"Global prevalence of depression in chronic kidney disease: A systematic review and meta-analysis","volume":"37","author":"OA Adejumo","year":"2024","journal-title":"J Nephrol"},{"issue":"12","key":"pone.0336467.ref039","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1017\/S0033291722003099","article-title":"A systematic review and meta-analysis of the evidence on inflammation in depressive illness and symptoms in chronic and end-stage kidney disease","volume":"53","author":"S Jayakumar","year":"2023","journal-title":"Psychol Med"},{"issue":"6","key":"pone.0336467.ref040","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/cid\/ciu919","article-title":"End-stage renal disease among HIV-infected adults in North America","volume":"60","author":"AG Abraham","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"pone.0336467.ref041","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00228-024-03714-5","article-title":"Risk of renal impairment in atypical antipsychotics: A systematic review and meta-analysis","volume":"80","author":"LT Ong","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"pone.0336467.ref042","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/ndt\/9.9.1250","article-title":"Kidney damage in long-term lithium patients: A cross-sectional study of patients with 15 years or more on lithium","volume":"9","author":"H Bendz","year":"1994","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"pone.0336467.ref043","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1523-1755.2003.00096.x","article-title":"Lithium-induced nephropathy: Rate of progression and prognostic factors","volume":"64","author":"C Presne","year":"2003","journal-title":"Kidney Int"},{"issue":"6","key":"pone.0336467.ref044","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.ajkd.2020.05.018","article-title":"The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Incident Frailty: An Analysis of the Cardiovascular Health Study (CHS)","volume":"76","author":"OA Potok","year":"2020","journal-title":"Am J Kidney Dis"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:47:39Z","timestamp":1781113659000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336467"}},"subtitle":[],"editor":[{"given":"Tinei","family":"Shamu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0336467","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}